Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1331 participants
OBSERVATIONAL
2013-01-01
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are limited data on the prognostic value of the SYNTAX-score among elderly patients.
Aim of this study was to investigate whether age modifies the impact of the SYNTAX-score on all-cause mortality at 2 years after percutaneous coronary intervention (PCI).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival
NCT03417050
Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia
NCT01373957
Intervention in Frailty Versus Usual Care in Frail Patients After an Acute Myocardial Infarction
NCT02715453
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
NCT00007657
Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?
NCT02750579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing PCI
all-comer population undergoing PCI
PCI
treatment of coronary arteries and evaluation of SYNTAX score pre and post (to quantify severity of disease)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PCI
treatment of coronary arteries and evaluation of SYNTAX score pre and post (to quantify severity of disease)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* no PCI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LMU Klinikum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Julinda Mehilli
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julinda Mehilli, MD
Role: PRINCIPAL_INVESTIGATOR
LMU Klinikum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ludwig-Maximilians University
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GEMucI003-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.